China Medicine newspaper (中国医药报) reported：Kalorama Information Inc. recently issued the "Global Cancer Diagnostics Market" study, estimating the 2009 global in vitro cancer diagnostic will reach $7.4 billion.

The study estimated that the global in vitro cancer diagnostic market will grow 13% annually. The demand for advanced cancer diagnostic products will continue to increase, and more and more new tests and new products will be used in joint treatment. Cancer drugs are gradually shifting from traditional cytotoxic chemotherapy to immune and biological treatments. In those new treatments, in vitro diagnostic products for monitoring drug therapeutic effect will be even more crucial. The study found that, the cancer research will be more and more investing in cancer screening and monitoring.